Oaktree Acquisition Corp. III Life Sciences Files 2024 Annual Report
Ticker: OACCU · Form: 10-K · Filed: Mar 27, 2025 · CIK: 2029769
| Field | Detail |
|---|---|
| Company | Oaktree Acquisition Corp. III Life Sciences (OACCU) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: spac, annual-report, life-sciences
TL;DR
Oaktree Acquisition Corp. III Life Sciences filed its 2024 10-K. Life sciences SPAC. Check financials.
AI Summary
Oaktree Acquisition Corp. III Life Sciences filed its 10-K for the fiscal year ended December 31, 2024. The company, incorporated in the Cayman Islands, is a blank check company focused on the life sciences sector. Its principal executive offices are located at 333 South Grand Avenue, Los Angeles, California.
Why It Matters
This filing provides a comprehensive overview of Oaktree Acquisition Corp. III Life Sciences' financial performance and business operations for the past fiscal year, crucial for investors assessing the company's status and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual report filing for a SPAC, providing routine financial and operational information.
Key Numbers
- 2024 — Fiscal Year End (The report covers the financial activities up to December 31, 2024.)
- 001-42383 — Commission File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Oaktree Acquisition Corp. III Life Sciences (company) — Registrant
- December 31, 2024 (date) — Fiscal year end
- Cayman Islands (location) — Jurisdiction of incorporation
- 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071 (address) — Principal Executive Offices
- 001-42383 (company_id) — Commission file number
FAQ
What is the primary business focus of Oaktree Acquisition Corp. III Life Sciences?
Oaktree Acquisition Corp. III Life Sciences is a blank check company focused on the life sciences sector.
In which jurisdiction was Oaktree Acquisition Corp. III Life Sciences incorporated?
The company was incorporated in the Cayman Islands.
What is the address of Oaktree Acquisition Corp. III Life Sciences' principal executive offices?
The principal executive offices are located at 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071.
For what fiscal year is this 10-K report filed?
This 10-K report is filed for the fiscal year ended December 31, 2024.
What is the commission file number for Oaktree Acquisition Corp. III Life Sciences?
The commission file number is 001-42383.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Oaktree Acquisition Corp. III Life Sciences (OACCU).